RPL presents further confirmation of the food effect on the QTc interval

Posted:
30
November 2012

Food produces a typical pattern QTcF shortening which is predictable, reproducible and can be demonstrated even in small populations of around 10 volunteers.Further to our publication �Shortening of the QT Interval After Food Can Be Used to Demonstrate Assay Sensitivity in Thorough QT Studies� published October 2012 in the Journal of Clinical Pharmacology, it is proposed that food effects on ECG demonstrated in SAD and MAD studies can be used to show assay sensitivity thereby enhancing the value of the ECG assessment in these studies significantly.Richmond Pharmacology will present on this topic at the 33rd Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics, taking place this year in Okinawa from 29 Nov to 1 Dec. The presentation will be held on Day 2, from 14h30-15h50 (Room 4 - Conference Hall B3+4).View programContact us to arrange a face-to-face meeting

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more